We have a large portfolio of products, including prescription medicines, vaccines and consumer healthcare brands, across a broad range of therapeutic areas.
All of our medicines are listed in alphabetical order in below table. By clicking on the underlined medicine name in the below table, you will be directed to the electronic Medicines Compendium (eMC), which contains up-to-date information about medicines licensed for use in the UK. Through this resource, you can access the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for all our medicines.
While this information may be helpful it is not intended to replace the advice of a doctor or other prescriber or other health professional.
Valproate▼ (Epilim and Depakote) Pregnancy Prevention Programme
Valproate is contraindicated in girls and women of childbearing potential unless the conditions of Prevent – the valproate pregnancy prevention programme are fulfilled.
Valproate Annual Risk Acknowledgement Form (ARAF)
This ARAF should be completed by girls and women of childbearing potential with their specialist. Your specialist should review your treatment and complete this form with you at least once a year to make sure you know and have understood all the risks related to the use of valproate during pregnancy and the need to avoid becoming pregnant while taking valproate.
Other Educational Materials for Patients taking Valproate
Other Educational Materials for Healthcare Professionals involved in the management of patients taking Valproate
Job bag number MAT-GB-2001218(v2.0)
Date of Preparation January 2022